/C O R R E C T I O N -- Ratio Therapeutics Inc./
In the news release, Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs, issued 30-Jun-2026 by Ratio Therapeutics Inc. over PR Newswire, we are advised by the company that changes have been made. The complete,...
In the news release, Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs, issued 30-Jun-2026 by Ratio Therapeutics Inc. over PR Newswire, we are advised by the company that changes have been made. The complete,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.